Cargando…

Cellular Immunity in COVID-19 Convalescents with PCR-Confirmed Infection but with Undetectable SARS-CoV-2–Specific IgG

We investigated immune responses against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among a group of convalescent, potential blood donors in Germany who had PCR-confirmed SARS-CoV-2 infection. Sixty days after onset of symptoms, 13/78 (17%) study participants had borderline or nega...

Descripción completa

Detalles Bibliográficos
Autores principales: Schwarzkopf, Sina, Krawczyk, Adalbert, Knop, Dietmar, Klump, Hannes, Heinold, Andreas, Heinemann, Falko M., Thümmler, Laura, Temme, Christian, Breyer, Marianne, Witzke, Oliver, Dittmer, Ulf, Lenz, Veronika, Horn, Peter A., Lindemann, Monika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7774536/
http://dx.doi.org/10.3201/eid2701.203772
_version_ 1783630286233272320
author Schwarzkopf, Sina
Krawczyk, Adalbert
Knop, Dietmar
Klump, Hannes
Heinold, Andreas
Heinemann, Falko M.
Thümmler, Laura
Temme, Christian
Breyer, Marianne
Witzke, Oliver
Dittmer, Ulf
Lenz, Veronika
Horn, Peter A.
Lindemann, Monika
author_facet Schwarzkopf, Sina
Krawczyk, Adalbert
Knop, Dietmar
Klump, Hannes
Heinold, Andreas
Heinemann, Falko M.
Thümmler, Laura
Temme, Christian
Breyer, Marianne
Witzke, Oliver
Dittmer, Ulf
Lenz, Veronika
Horn, Peter A.
Lindemann, Monika
author_sort Schwarzkopf, Sina
collection PubMed
description We investigated immune responses against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among a group of convalescent, potential blood donors in Germany who had PCR-confirmed SARS-CoV-2 infection. Sixty days after onset of symptoms, 13/78 (17%) study participants had borderline or negative results to an ELISA detecting IgG against the S1 protein of SARS-CoV-2. We analyzed participants with PCR-confirmed infection who had strong antibody responses (ratio >3) as positive controls and participants without symptoms of SARS-CoV-2 infection and without household contact with infected patients as negative controls. Using interferon-γ ELISpot, we observed that 78% of PCR-positive volunteers with undetectable antibodies showed T cell immunity against SARS-CoV-2. We observed a similar frequency (80%) of T-cell immunity in convalescent donors with strong antibody responses but did not detect immunity in negative controls. We concluded that, in convalescent patients with undetectable SARS-CoV-2 IgG, immunity may be mediated through T cells.
format Online
Article
Text
id pubmed-7774536
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-77745362021-01-01 Cellular Immunity in COVID-19 Convalescents with PCR-Confirmed Infection but with Undetectable SARS-CoV-2–Specific IgG Schwarzkopf, Sina Krawczyk, Adalbert Knop, Dietmar Klump, Hannes Heinold, Andreas Heinemann, Falko M. Thümmler, Laura Temme, Christian Breyer, Marianne Witzke, Oliver Dittmer, Ulf Lenz, Veronika Horn, Peter A. Lindemann, Monika Emerg Infect Dis Research We investigated immune responses against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among a group of convalescent, potential blood donors in Germany who had PCR-confirmed SARS-CoV-2 infection. Sixty days after onset of symptoms, 13/78 (17%) study participants had borderline or negative results to an ELISA detecting IgG against the S1 protein of SARS-CoV-2. We analyzed participants with PCR-confirmed infection who had strong antibody responses (ratio >3) as positive controls and participants without symptoms of SARS-CoV-2 infection and without household contact with infected patients as negative controls. Using interferon-γ ELISpot, we observed that 78% of PCR-positive volunteers with undetectable antibodies showed T cell immunity against SARS-CoV-2. We observed a similar frequency (80%) of T-cell immunity in convalescent donors with strong antibody responses but did not detect immunity in negative controls. We concluded that, in convalescent patients with undetectable SARS-CoV-2 IgG, immunity may be mediated through T cells. Centers for Disease Control and Prevention 2021-01 /pmc/articles/PMC7774536/ http://dx.doi.org/10.3201/eid2701.203772 Text en https://creativecommons.org/licenses/by/4.0/This is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited.
spellingShingle Research
Schwarzkopf, Sina
Krawczyk, Adalbert
Knop, Dietmar
Klump, Hannes
Heinold, Andreas
Heinemann, Falko M.
Thümmler, Laura
Temme, Christian
Breyer, Marianne
Witzke, Oliver
Dittmer, Ulf
Lenz, Veronika
Horn, Peter A.
Lindemann, Monika
Cellular Immunity in COVID-19 Convalescents with PCR-Confirmed Infection but with Undetectable SARS-CoV-2–Specific IgG
title Cellular Immunity in COVID-19 Convalescents with PCR-Confirmed Infection but with Undetectable SARS-CoV-2–Specific IgG
title_full Cellular Immunity in COVID-19 Convalescents with PCR-Confirmed Infection but with Undetectable SARS-CoV-2–Specific IgG
title_fullStr Cellular Immunity in COVID-19 Convalescents with PCR-Confirmed Infection but with Undetectable SARS-CoV-2–Specific IgG
title_full_unstemmed Cellular Immunity in COVID-19 Convalescents with PCR-Confirmed Infection but with Undetectable SARS-CoV-2–Specific IgG
title_short Cellular Immunity in COVID-19 Convalescents with PCR-Confirmed Infection but with Undetectable SARS-CoV-2–Specific IgG
title_sort cellular immunity in covid-19 convalescents with pcr-confirmed infection but with undetectable sars-cov-2–specific igg
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7774536/
http://dx.doi.org/10.3201/eid2701.203772
work_keys_str_mv AT schwarzkopfsina cellularimmunityincovid19convalescentswithpcrconfirmedinfectionbutwithundetectablesarscov2specificigg
AT krawczykadalbert cellularimmunityincovid19convalescentswithpcrconfirmedinfectionbutwithundetectablesarscov2specificigg
AT knopdietmar cellularimmunityincovid19convalescentswithpcrconfirmedinfectionbutwithundetectablesarscov2specificigg
AT klumphannes cellularimmunityincovid19convalescentswithpcrconfirmedinfectionbutwithundetectablesarscov2specificigg
AT heinoldandreas cellularimmunityincovid19convalescentswithpcrconfirmedinfectionbutwithundetectablesarscov2specificigg
AT heinemannfalkom cellularimmunityincovid19convalescentswithpcrconfirmedinfectionbutwithundetectablesarscov2specificigg
AT thummlerlaura cellularimmunityincovid19convalescentswithpcrconfirmedinfectionbutwithundetectablesarscov2specificigg
AT temmechristian cellularimmunityincovid19convalescentswithpcrconfirmedinfectionbutwithundetectablesarscov2specificigg
AT breyermarianne cellularimmunityincovid19convalescentswithpcrconfirmedinfectionbutwithundetectablesarscov2specificigg
AT witzkeoliver cellularimmunityincovid19convalescentswithpcrconfirmedinfectionbutwithundetectablesarscov2specificigg
AT dittmerulf cellularimmunityincovid19convalescentswithpcrconfirmedinfectionbutwithundetectablesarscov2specificigg
AT lenzveronika cellularimmunityincovid19convalescentswithpcrconfirmedinfectionbutwithundetectablesarscov2specificigg
AT hornpetera cellularimmunityincovid19convalescentswithpcrconfirmedinfectionbutwithundetectablesarscov2specificigg
AT lindemannmonika cellularimmunityincovid19convalescentswithpcrconfirmedinfectionbutwithundetectablesarscov2specificigg